首页 > 市场调查报告书 > 医疗设备

美容整形

北美神经毒素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型、应用和最终用户

市场调查报告书

商品编码

1375139

北美神经毒素市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型、应用和最终用户

North America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User

出版日期: 2023年08月24日 | 出版商:

The Insight Partners | 英文 99 Pages | 订单完成后即时交付

价格

简介目录图表

北美神经毒素市场预计将从2023年的48.0129亿美元成长到2028年的84.1695亿美元。预计2023年至2028年复合年增长率为11.9%。

创新脸部美容产品的出现推动了北美神经毒素市场

预计神经毒素的整体市场将在预测期内呈指数级增长，以满足日益增长的脸部美容需求。 2022年3月，Aquavit Pharmaceuticals, Inc.宣布提交「DTX-021」的研究新药（IND），这是一种A型肉毒桿菌毒素，旨在治疗中度至重度眉间纹。本产品是一种高度纯化且经过临床测试的可注射神经调节剂，含有源自肉毒桿菌产生的神经毒素的 900 kDa 蛋白质复合物。此外，Aquavit 正在透过推出 DTX-022 加速临床试验，其最终批准将被认为是首个、也是世界上第一个全面部微注射神经毒素的产品。同样，随着减重趋势的持续，胃肉毒桿菌已成为寻求非侵入性手术的患者的热门选择。它涉及使用内视镜技术将肉毒桿菌注射到特定的胃部区域。透过这种技术，可以抑制胃部肌肉的收缩。由于这种限制，胃的排空过程需要更长的时间，这导致患者长时间感到饱腹感，导致食慾下降并改善与体重相关的健康问题/生活方式障碍，例如高血压和糖尿病。因此，创新脸部美容产品的出现有助于北美神经毒素市场的成长。

北美神经毒素市场概况

北美神经毒素市场分为美国、加拿大和墨西哥。美国是最大且成长最快的神经毒素市场。该地区的市场增长归因于产品推出的增加、FDA 对用于各种肌肉疾病的神经毒素的批准不断增加、人口老龄化、非手术或微创美容手术数量的增加、美容手术数量的增加以及对神经毒素的需求不断增长微创治疗。

北美神经毒素市场收入及 2028 年预测（百万美元）

北美神经毒素市场细分

北美神经毒素市场按产品类型、应用、最终用户和国家细分。根据产品类型，北美神经毒素市场细分为肉毒桿菌、dysport、xenomin 等。肉毒桿菌细分市场在 2023 年占据最大的市场份额。

根据应用，北美神经毒素市场分为治疗和美容市场。 2023 年，治疗领域占据更大的市场份额。

根据最终用户，北美神经毒素市场分为医院、专科诊所、皮肤科诊所等。 2023 年，医院细分市场占据最大市场份额。

根据国家/地区，北美神经毒素市场分为美国、加拿大和墨西哥。 2023 年，美国占据市场份额主导地位。

AbbVie Inc、Hugel Inc、Ipsen SA、Meditox Inc、Merz Pharma GmbH & Co KGaA、Metabiologics 和 Revance Therapeutics Inc 是北美神经毒素市场的领导公司。

The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the North America neurotoxin market to grow.

North America Neurotoxins Market Overview

The North America neurotoxin market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for neurotoxins. The market growth in the region is attributed to the increasing product launches, growing FDA approvals for neurotoxins for various muscular conditions, rising aging population, increasing numbers of non-surgical or minimally invasive cosmetic procedures, increasing number of aesthetic procedures, and growing demand for minimally invasive therapeutics.

North America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)

North America Neurotoxins Market Segmentation

The North America neurotoxins market is segmented into product type, application, end user, and country. Based on product type, the North America neurotoxins market is sub segmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.

Based on application, the North America neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.

Based on end user, the North America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.

Based on country, the North America neurotoxins market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.

AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, Merz Pharma GmbH & Co KGaA, Metabiologics, and Revance Therapeutics Inc are among the leading companies operating in the North America neurotoxins market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurotoxins market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Neurotoxin Market - by Type
- 1.3.2 North America Neurotoxin Market - by Application
- 1.3.3 North America Neurotoxin Market - by End User
- 1.3.4 North America Neurotoxin Market - by Country

2. North America Neurotoxin Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Neurotoxin Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion

5. North America Neurotoxin Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
- 5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
- 5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
- 5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
- 5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis

6. North America Neurotoxin Market

6.1 North America Neurotoxin Market Revenue Forecast and Analysis

7. North America Neurotoxin Market - Revenue and Forecast to 2028 - By Type

7.1 Overview
7.2 North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
- 7.4.1 Overview
- 7.4.2 Dysport: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
- 7.5.1 Overview
- 7.5.2 Xeomin: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Neurotoxin Market - Revenue and Forecast to 2028 - By Application

8.1 Overview
8.2 North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
- 8.3.1 Overview
- 8.3.2 Therapeutic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
- 8.4.1 Overview
- 8.4.2 Aesthetic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Neurotoxin Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 North America Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
- 9.4.1 Overview
- 9.4.2 Medical Spas and Beauty Centers: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
- 9.5.1 Overview
- 9.5.2 Dermatology Clinics: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis

10.1 Overview
- 10.1.1 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
  - 10.1.1.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)

11. North America Neurotoxins Market-Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merz Pharma GmbH & Co KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Revance Therapeutics Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Ipsen SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Medytox Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Hugel Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Metabiologics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Neurotoxins Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Neurotoxins Market
Table 12. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 13. Glossary of Terms

List Of Figures

Figure 1. North America Neurotoxin Market Segmentation
Figure 2. North America Neurotoxin Market by Country
Figure 3. North America Neurotoxin Market Overview
Figure 4. North America Neurotoxin Market, By Type
Figure 5. North America Neurotoxin Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8. North America Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 9. North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10. Botox: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Dysport: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Xeomin: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15. Therapeutic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Aesthetic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18. Hospitals: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Medical Spas and Beauty Centers: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatology Clinics: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24. US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)